-35%

est. 2Y upside i

HealthcareSeries B

Rank

#1971

Sector

Healthtech

Est. Liquidity

~3Y

Data Quality

Data: Medium

CareStack presents a moderate upside opportunity for a job seeker.

Last updated: March 10, 2026

Bull (30%)+150%

CareStack successfully expands its market penetration by leveraging AI and strategic partnerships, capturing significant share from fragmented competitors. Revenue grows to over $300M by 2028, justifying a $2.5B+ valuation at 8-10x revenue, driven by strong product adoption and efficient RCM services.

Base (40%)+50%

CareStack maintains its strong position in the cloud-based dental software market, growing steadily at 25-35% annually. It continues to innovate within its niche, reaching approximately $170M in revenue by 2028 and achieving a $1.5B valuation, reflecting solid execution and market presence.

Bear (30%)-50%

Increased competition from incumbents like Henry Schein, who actively acquire and integrate competing solutions, leads to market share erosion and pricing pressure. Growth slows significantly, and the company struggles to raise further capital at a favorable valuation, resulting in a down round or exit at $500M, wiping out a substantial portion of common stock value after liquidation preferences.

Est. time to liquidity~3.0 years

Preference Stack Risk

moderate

With $145M in total funding and an estimated current valuation of $1B, investors hold approximately 14.5% in liquidation preferences ahead of common shareholders.

Dilution Risk

moderate

As a Series C+ company, there is a moderate risk of further dilution from future funding rounds, although the company's capital intensity is low.

Secondary Liquidity

limited

While private secondary markets like Nasdaq Private Market exist for accredited investors, direct employee liquidity options are likely limited and depend on company-initiated tender offers or specific investor interest.

View all 71 open roles at Carestack →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Carestack's data — designed to show you've done your homework.

  • 1

    “Given Henry Schein's recent acquisition of Biotech Dental's practice management software, how does CareStack plan to differentiate and maintain its competitive edge against such well-resourced incumbents in the long term?”

  • 2

    “CareStack's revenue model includes SaaS subscriptions, RCM, and patient financing. How do you see the contribution of each of these streams evolving over the next 2-3 years to drive overall revenue growth and profitability?”

  • 3

    “With the last known funding round in late 2022, what is the company's current thinking on the timeline for a potential liquidity event, and how are employee equity packages being managed in anticipation of future funding or exit scenarios?”

Community

Valuation Sentiment

Our model estimates -35% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.